Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. It is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. It provides periodic on-site services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 27.90% year-on-year.
Fairly Valued
The company’s latest PB is 2.80, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 10.05M shares, decreasing 3.77% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 561.75K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.72.